Phosphorus Bonded Directly To Halogen Patents (Class 514/139)
  • Patent number: 11273167
    Abstract: The present disclosure provides compositions and methods of modulating abhydrolase domain-containing protein-2 (ABHD2). The present disclosure provides methods of identifying agents that modulate ABHD2 activity.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: March 15, 2022
    Assignee: The Regents of the University of California
    Inventors: Polina V. Lishko, Yuriy Kirichok, Melissa R. Miller
  • Publication number: 20140349976
    Abstract: As disclosed herein, co-administration of pimavanserin with an agent that ameliorates one or more cholinergic abnormalities can have a synergistic effect on the efficacy of the agent. Disclosed herein are compositions which include pimavanserin in combination with an agent that ameliorates one or more cholinergic abnormalities. Also disclosed herein are methods for ameliorating or treating a disease condition characterized by one or more cholinergic abnormalities that can include administering pimavanserin in combination with an agent that ameliorates one or more cholinergic abnormalities.
    Type: Application
    Filed: May 28, 2014
    Publication date: November 27, 2014
    Applicant: Acadia Pharmaceuticals Inc.
    Inventors: Uli HACKSELL, Krista MCFARLAND
  • Patent number: 8293724
    Abstract: Fatty acid amide hydrolase (FAAH) is an enzyme responsible for the degradation of oleamide (an endogenous sleep-inducing lipid) and anandamide (an endogenous ligand for cannabinoid receptors). Disclosed herein are potent inhibitors of FAAH and methods for their use for treating a variety of disorder, including hypertension and cardiac hypertrophy.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: October 23, 2012
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: George Kunos, Alexandros Makriyannis
  • Patent number: 8221737
    Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: July 17, 2012
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Xiaowen Peng, Lu Ying, Ce Wang, Yao-Ling Qiu
  • Publication number: 20110052656
    Abstract: A process has been found which increases the efficiency and effectiveness of introducing antimicrobial compounds into complex biofilm matrices through the use of liposome carriers, thereby removing the biofouling in industrial water bearing systems, including piping, heat exchanges, condensers, filtration systems and fluid storage tanks. According to one embodiment of the invention, antimicrobial compound containing liposomes are added to water systems prone to biofouling and biofilm formation. The liposomes, being similar in composition to microbial membranes or cells, are readily incorporated into the existing biofilm. Once the antimicrobial compound containing liposomes become entrained with the biofilm matrix, the decomposition or programmed disintegration of the liposome proceeds. Thereafter, the biocidal aqueous core is released to react directly with the biofilm encased microorganisms.
    Type: Application
    Filed: September 28, 2010
    Publication date: March 3, 2011
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Wilson Kurt Whitekettle, Gloria Jean Tafel, Qing Zhao, Linna Wang, Dorothy Reynolds, Paul Frail, Juan Jiang, David M. Polizzotti
  • Publication number: 20100331280
    Abstract: There is provided a method of modifying vasoactivity by regulating a soluble A? pro-inflammatory pathway. Also provided is a method of modifying inflammatory reactions in microglia and neurons by regulating a soluble A? pro-inflammatory pathway. A method of treating patients with vascular disease by modifying an intracellular soluble A? pro-inflammatory pathway is also provided. A pharmaceutical composition consisting essentially of an effective amount of a soluble A? pro-inflammatory pathway regulator in a pharmaceutically effective carrier is also provided.
    Type: Application
    Filed: October 20, 2009
    Publication date: December 30, 2010
    Inventors: Daniel C. Paris, Terrence C. Town, Michael J. Mullan
  • Publication number: 20100261674
    Abstract: Fatty acid amide hydrolase (FAAH) is an enzyme responsible for the degradation of oleamide (an endogenous sleep-inducing lipid) and anandamide (an endogenous ligand for cannabinoid receptors). Disclosed herein are potent inhibitors of FAAH and methods for their use for treating a variety of disorder, including hypertension and cardiac hypertrophy.
    Type: Application
    Filed: April 6, 2010
    Publication date: October 14, 2010
    Inventors: George Kunos, Alexandros Makriyannis
  • Publication number: 20090156561
    Abstract: A method of causing a patient to reduce or cease tobacco use that involves the administration of a cholinesterase inhibitor.
    Type: Application
    Filed: June 17, 2008
    Publication date: June 18, 2009
    Inventor: John C. Seed
  • Patent number: 7033580
    Abstract: Disclosed is a safe and effective hair-growing agent comprising a protein kinase C-specific inhibitor.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: April 25, 2006
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Tomoya Takahashi, Yoshiharu Yokoo, Toshikazu Kamiya, Akio Shirai, Tatsuya Tamaoki
  • Patent number: 6762183
    Abstract: The invention relates to novel active compound combinations of certain cyclic ketoenols and certain active compounds that together have unexpectedly good insecticidal and acaricidal properties.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: July 13, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Reiner Fischer, Christoph Erdelen, Thomas Bretschneider
  • Patent number: 6566304
    Abstract: The invention relates to use of (a) compounds of phosphorus containing at least partly lipophilic organic radicals together with (b) urea and/or urea derivatives in selected quantity ratios of (a) to (b) as a soil additive for biologically controlling plant-parasitic soil nematodes by strengthening the correspondingly antagonistic soil potential, more particularly by strengthening the growth of antagonistic and/or nematicidal rhizosphere bacteria and/or corresponding mycorrhiza strains—and at the same time strengthening the growth of cultivated plants in soil. The multicomponent mixtures which strengthen bacterial growth are preferably introduced into the region of the plant roots in the form of an aqueous preparation using plant-compatible emulsifiers before and/or during plant growth. Components (a) and (b) are used in such quantity ratios that the ratio by weight of C to N is no higher than 6:1 and preferably no higher than 5:1.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: May 20, 2003
    Assignee: Cognis Deutschland GmbH
    Inventors: Doris Bell, Bettina Kopp-Holtwiesche, Stephan Von Tapavicza
  • Patent number: 6506370
    Abstract: Disclosed is a safe and effective hair-growing agent comprising a protein kinase C-specific inhibitor.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: January 14, 2003
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Tomoya Takahashi, Yoshiharu Yokoo, Toshikazu Kamiya, Akio Shirai, Tatsuya Tamaoki
  • Patent number: 6506737
    Abstract: An oxidizing species is described herein as a reaction product through an in situ preparation combining a protonizable phosphorus or sulfur compound, and a halide source at controlled proportions in an aqueous, non-aqueous, gel, aerosol, solid-phase or powdered media. The oxidizing species can be used to reduce microbial and viral populations on a surface or object or in a body or stream of water. The invention thus finds applications as a bleach, sanitizer, oxidant, or in any other application in which an oxidizing agent can be beneficially used alone or in a formulation.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: January 14, 2003
    Assignee: Ecolab, Inc.
    Inventors: Robert D. P. Hei, Kim Smith
  • Patent number: 6429203
    Abstract: Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: August 6, 2002
    Assignee: International Phytochemistry Research Labs, Ltd.
    Inventors: Tattym E. Shaikenov, Sergazy M. Adekenov
  • Patent number: 6127465
    Abstract: Disclosed is a polycarbonate resin composition comprising an aromatic polycarbonate (PC), a high-impact polystyrene resin (HIPS) and a non-halogen phosphate, and also talc and/or polytetrafluoroethylene (PTFE). Optionally, the composition may contain a core/shell-type, grafted, rubber-like elastic material. The composition has good flame retardancy and has good physical properties such as stiffness, impact resistance, outward appearance and flowability.
    Type: Grant
    Filed: September 4, 1997
    Date of Patent: October 3, 2000
    Assignee: Idemitsu Petrochemical Co., Ltd.
    Inventor: Akio Nodera
  • Patent number: 6051565
    Abstract: Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: April 18, 2000
    Assignee: International Phytochemistry Research Labs, Ltd.
    Inventors: Tattym E. Shaikenov, Sergazy M. Adekenov
  • Patent number: 5972349
    Abstract: Polyribosylribitol phosphate oligosaccharides are produced in a multistep process. The compound of the formula: ##STR1## wherein R.sub.1 is a first protecting group and R.sub.2 is a second protecting group, is coupled to a solid polyethylene glycol monomethyl ether (PEG) support. Following removal of the first protecting group, the resulting compound is coupled with a repeating unit for chain elongation of the formula: ##STR2## The protecting group is removed from the phosphorus atom and the steps of removing the first protecting group, coupling with the repeating unit is repeated until the desired number of repeating units in the oligomer has been terminated. The oligomer then is terminated with a chain terminating molecule of the formula: ##STR3## wherein m is an integer and R.sub.3 is a third protecting group.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 26, 1999
    Assignee: Connaught Laboratories Limited
    Inventors: Pele Chong, Ali Kandil, Charles Sia, Michel Klein
  • Patent number: 5969017
    Abstract: This application discloses a method of treating or preventing atrial arrhythmias which utilizes compounds which are blockers of the ultra-rapidly-activating delayed rectifier K.sup.+ current (I.sub.Kur) of the human atrium in a use-dependent and/or rate dependent manner, and which provide the selective block preferentially at fast heart rates so that the effect is realized or maximized when required.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: October 19, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Joseph J. Lynch, Jr., Richard J. Swanson, Joseph J. Salata, Bernard Fermini
  • Patent number: 5723486
    Abstract: Disclosed are 1,3-dithiolo(4,5-d)-1,3-dithiino-2-thione compounds corresponding to one of the formulae: ##STR1## wherein R.sup.1 represents --Br, --Cl, --F, --CN or --CH(CH.sub.2).sub.n CH.sub.3 and n is an integer of from 0 to 10.These compounds as well as the unsubstituted compound have been found to exhibit antimicrobial and marine antifouling activity in industrial and commercial applications and compositions containing these compounds are so employed.
    Type: Grant
    Filed: July 10, 1996
    Date of Patent: March 3, 1998
    Assignee: The Dow Chemical Company
    Inventors: Weishi W. Wu, Duane R. Romer, Ravi B. Shankar, R. Garth Pews
  • Patent number: 5709890
    Abstract: An insecticide composition is enhanced from the standpoint of its ability to be absorbed by insects, such as red fire ants, particularly dithiophosphate ester pesticides by the addition of a small amount of a water soluble non-aromatic polyorganic acid or salt form thereof such as polyaspartic acid, particularly preferred with a molecular weight in the range of about 3000 to 40,000.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: January 20, 1998
    Assignee: Donlar Corporation
    Inventor: J. Larry Sanders
  • Patent number: 5646133
    Abstract: An insecticide composition is enhanced from the standpoint of its ability to be absorbed by insects, such as red fire ants, particularly dithiophosphate ester pesticides by the addition of a small amount of a water soluble non-aromatic polyorganic acid or salt form thereof such as polyaspartic acid, particularly preferred with a molecular weight in the range of about 3000 to 40,000.
    Type: Grant
    Filed: March 14, 1996
    Date of Patent: July 8, 1997
    Assignee: Donlar Corporation
    Inventor: J. Larry Sanders
  • Patent number: 5186947
    Abstract: Water-soluble wood preservatives which contain mixtures of a metal compound, a metal-fixing acid and a complexing polymeric nitrogen compound, and methods for protecting wood with such mixtures.
    Type: Grant
    Filed: September 19, 1991
    Date of Patent: February 16, 1993
    Assignee: Dr. Wolman GmbH
    Inventors: Reimer Goettsche, Wolfgang Reuther
  • Patent number: 5139561
    Abstract: A method for protecting growing plants against fungal or microbial plant pathogens which comprises applying thereto, or to the medium on which they are growing or to be grown, a composition comprising a water soluble tetrakis (hydroxymethyl) phosphonium salt.
    Type: Grant
    Filed: July 19, 1991
    Date of Patent: August 18, 1992
    Assignee: Albright & Wilson Limited
    Inventors: Robert E. Talbot, Kenneth G. Cooper
  • Patent number: 5102874
    Abstract: Antimicrobial mixtures contain quaternary ammonium compounds and quaternary phosphonium compounds in a ratio by weight of from 1:9 to 9:1.
    Type: Grant
    Filed: August 20, 1990
    Date of Patent: April 7, 1992
    Assignee: Ecolab Inc.
    Inventors: Karl Lintner, Reinhard Orth, Rudolf Lehmann, Hans-Juergen Mueller
  • Patent number: 4927855
    Abstract: The levorotatory isomer of benzhydrylsulfinylacetamide has useful pharmaceutical activity on the central nervous system, particularly as an antidepressant and stimulant in the treatment of hypersomnia and Alzheimer's disease.
    Type: Grant
    Filed: January 28, 1987
    Date of Patent: May 22, 1990
    Assignee: Laboratoire L. Lafon
    Inventor: Louis Lafon
  • Patent number: 4874526
    Abstract: A process for treating water which comprises adding to the water (a) from 1 to 50 ppm of a phosphonium compound of the formula: ##STR1## in which R represents C.sub.1 -C.sub.6 groups which are unsubstituted or substituted by a cyano, hydroxy, esterified hydroxy or aryl group, R.sub.1 represents a C.sub.8 -C.sub.18 alkyl group and X represents chlorine or bromine, and optionally (b) from 0.1 to 100 ppm of an anionic water treatment agent such as a scale or corrosion inhibiting agent.
    Type: Grant
    Filed: May 26, 1988
    Date of Patent: October 17, 1989
    Assignee: Ciba-Geigy Corporation
    Inventors: Reinhardt Grade, Brien M. Thomas
  • Patent number: 4708869
    Abstract: A method and composition for causing casualties among mammals by contacting composition comprising casuality producing chemical agents, thickener and open multicellular polymer and said composition covering various external surfaces.
    Type: Grant
    Filed: September 2, 1969
    Date of Patent: November 24, 1987
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Abraham Koblin
  • Patent number: 4673509
    Abstract: The growth of microbiological contaminants in industrial cooling and process waters and in aqueous based products, susceptible to microbiological spoilage on storage, is inhibited by the presence of a phosphorus compound having a hydroxy alkyl group directly attached to the phosphorus atom, such as tetrakis hydroxy methyl phosphonium sulphate.
    Type: Grant
    Filed: August 27, 1984
    Date of Patent: June 16, 1987
    Assignee: Albright & Wilson Limited
    Inventors: Keith P. Davis, Robert E. Talbot
  • Patent number: 4632946
    Abstract: A halogen-free flameproofed thermoplastic molding material consists of a halogen-free thermoplastic resin (A) and one or more further halogen-free components.The thermoplastic resin (A) is present in an amount of from 30 to 90% by weight, based on the molding material. The latter contains, as further components, from 1 to 50% by weight of a phenol/aldehyde resin (B), from 1 to 50% by weight of a nitrogen-containing organic compound (C) and from 3 to 50% by weight of a phosphorus-containing organic compound (D), the percentages in each case being based on the molding material.The molding material is used for the production of flameproofed moldings.
    Type: Grant
    Filed: January 18, 1985
    Date of Patent: December 30, 1986
    Assignee: BASF Aktiengesellschaft
    Inventors: Volker Muench, Juergen Hambrecht, Adolf Echte, Karl H. Illers, Johann Swoboda